Literature DB >> 14905420

Clinical observations on the use of triethylenemelamine.

E D BAYRD, J M STICKNEY, B E HALL, C H WATKINS.   

Abstract

Entities:  

Keywords:  NEOPLASMS/therapy; TRIETHYLENE MELAMINE/therapeutic use

Mesh：

Substances：

Year:  1952        PMID： 14905420     DOI： 10.1002/1097-0142(195203)5:2<336::aid-cncr2820050222>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  TRYPSIN in thrombo-embolic disease.

Authors: 
Journal:  Br Med J       Date:  1955-06-04

2.  Chemotherapy of cancer.

Authors:  K A NEWTON
Journal:  Postgrad Med J       Date:  1958-12       Impact factor: 2.401

3.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01

4.  The chemotherapy of malignant disease.

Authors:  R B SCOTT
Journal:  Br Med J       Date:  1958-01-04

5.  [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].

Authors:  H MARTIN
Journal:  Klin Wochenschr       Date:  1953-03-15

6.  BACTERIA at the sea bottom.

Authors: 
Journal:  Br Med J       Date:  1952-06-21

7.  Current trends in cancer chemotherapy.

Authors:  B E HALL; F M WILLETT; T V FEICHTMEIR; E B REED; W F DOWLING
Journal:  Calif Med       Date:  1956-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.